AGIO Competitors & Alternatives
Compare Agios Pharm with similar stocks in the same industry
Biotechnology
AGIO
Main Stock$37.58
Tradestie Score
59
Market Cap
$2.33B
Revenue Growth
1.4%
Analyst Upside
+8.4%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$25.81
|
$2.37B | - | 59 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.91
|
$2.35B | - | 59 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$9.44
|
$2.34B | - | 56 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.26
|
$2.33B | - | 64 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.80
|
$2.23B | - | 57 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$21.19
|
$2.22B | - | 64 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$56.92
|
$2.21B | - | 61 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$25.83
|
$2.18B | - | 61 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.38
|
$2.08B | - | 50 | Compare |
More AGIO Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry